| AI | artificial intelligence |
| BCG | Bacillus Calmette–Guérin |
| CagA | cytotoxin-associated gene A |
| CMC | Chemistry Manufacturing and Controls |
| COX-2 | cyclooxygenase-2 |
| CQAs | critical quality attributes |
| DDS | drug delivery systems |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| EGFR | epidermal growth factor receptor |
| EMR | Eradicate-Modulate-Regenerate |
| EPS | extracellular polymeric substances |
| GRDDS | gastro-retentive drug delivery systems |
| GRT | gastric residence time |
| HDDT | high-dose dual therapy |
| HIF | hypoxia-inducible factor |
| HO-1 | heme oxygenase-1 |
| IFN-γ | interferon-γ |
| IL-10 | interleukin-10 |
| MHC | major histocompatibility complex |
| MIC | minimum inhibitory concentration |
| miRNAs | microRNAs |
| MOFs | metal–organic frameworks |
| MSNs | mesoporous silica nanoparticles |
| NF-κB | nuclear factor kappa B |
| NLCs | nanostructured lipid carriers |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| PHD | prolyl hydroxylase domain |
| PDT | photodynamic therapy |
| PPIs | proton pump inhibitors |
| PTT | photothermal therapy |
| QbD | quality by design |
| RCTs | randomized controlled trials |
| ROS | reactive oxygen species |
| RNS | reactive nitrogen species |
| RR | risk ratio |
| RWE | real-world evidence |
| SCFAs | short-chain fatty acids |
| SOD | superoxide dismutase |
| TFFs | trefoil factor family |
| TFF2 | trefoil factor 2 |
| TGF-β | transforming growth factor-β |
| TJs | tight junctions |
| TLRs | toll-like receptors |
| TLR4 | Toll-like receptor 4 |
| TNF-α | tumor necrosis factor-α |
| Tregs | regulatory T cells |
| Th1 | T helper 1 |
| Th17 | T helper 17 |
| TSG-6 | tumor necrosis factor-stimulated gene-6 |
| VacA | vacuolating cytotoxin A. |